{"title":"Palpebral Edema and Microcytic Anemia in a 2 Year-old Female with an Excessive intake of Cow’s Milk","authors":"R. Hopp","doi":"10.24966/ADT-749X/100012","DOIUrl":"https://doi.org/10.24966/ADT-749X/100012","url":null,"abstract":"","PeriodicalId":331391,"journal":{"name":"Allergy Disorders & Therapy","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133506605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Expanding the Boundaries of Oral Probiotic Formulations to Target Atopic Dermatitis","authors":"Y. Padeh","doi":"10.24966/ADT-749X/100010","DOIUrl":"https://doi.org/10.24966/ADT-749X/100010","url":null,"abstract":"Expanding the Boundaries of Oral Probiotic Formu- lations to Target Atopic Dermatitis. Abstract Rationale: Some clinical trials already demonstrate statistically significant improvement of AD symptoms with oral probiotics. The addition of regulatory T-cell (Treg)-enhancing vitamins and amino acid cofactors and improved gut delivery of viable probiotic organ isms could further increase the efficacy of probiotics in reducing AD symptoms. Purpose: The aim of this pilot study is to show the efficacy of a novel formulation of probiotics and vitamins specifically targeted for improving Atopic Dermatitis (AD) symptoms. Methods: A novel Targeted Probiotics and Vitamin Complex (TPVC) was formulated, consisting of prebiotics, 11 probiotic strains, Vitamin D, Vitamin A, and L-tryptophan. It utilizes a patented micro-encap sulation technology which allows it to deliver a higher yield of viable probiotic organisms to the small and large intestines compared to other probiotic formulations such as liquids, powders, or capsules. The TPVC was offered as a free sample (60 pills) to interest AD pa tients ages 6-years-old and older, with parental consent for minors (ages 6 through 17-years-old). Data on symptoms was collected with the validated Patient Oriented Eczema Measure (POEM) self-as sessment survey tool which was completed by patients or parents of minors prior to starting the TPVC as well as after taking it daily for at least two consecutive weeks. Results: Forty-eight interested patients/parents with AD accepted samples of the TPVC. Seventeen of the 48 patients/parents complet ed the pre-treatment POEM survey. Of those seventeen, 9 patients/ parents completed the post-treatment POEM survey. Pre-treatment POEM scores ranged from 3 to 20. Post-treatment POEM scores ranged from 10. The 9 changes were and ranged from 3 16 where a of 3.4 greater has been established as a clinically meaningful improvement. Only 2 patients had a score of 3, while 7 had an improvement of 4 or greater. Conclusion: The TPVC, a novel probiotic formulation utilizing 11 different probiotic species combined with Vitamins A and D and the amino acid L-tryptophan and designed to deliver a high yield of via ble organisms past the stomach, improved the AD symptoms of 7 out of 9 patients to a clinically meaningful degree.","PeriodicalId":331391,"journal":{"name":"Allergy Disorders & Therapy","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129344345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Long Term Remission of Hyper IgE Syndrome after Treatment with Cyclosporine-A: Clinic and Immunological Correlations","authors":"Harb A Harfi","doi":"10.24966/adt-749x/100009","DOIUrl":"https://doi.org/10.24966/adt-749x/100009","url":null,"abstract":"","PeriodicalId":331391,"journal":{"name":"Allergy Disorders & Therapy","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122718345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Implications of Allergic Reactions to Soybean Oil","authors":"San Miguel-Hernández A","doi":"10.24966/adt-749x/100008","DOIUrl":"https://doi.org/10.24966/adt-749x/100008","url":null,"abstract":"Soybeans oil both cold-pressed and fully refined oils have been shown to contain proteins. Although most publications suggest that refined oils do not induce allergic reactions in sensitive individuals, adverse reaction to soy oil in an infant has been reported. Is used in cooking and food formulations. The presence of protein in soy oil depends on the degree of refining, as for other seed oils","PeriodicalId":331391,"journal":{"name":"Allergy Disorders & Therapy","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123792055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effect of Genetic Factors on Atopic and Non Atopic Asthmatic and Allergic Rhinitis Saudi Children in Taif Area","authors":"Yousri M Hussein","doi":"10.24966/adt-749x/100007","DOIUrl":"https://doi.org/10.24966/adt-749x/100007","url":null,"abstract":"To assess the value of serum Interleukin-13 (IL-13) levels as an immunological marker in atopic upper respiratory diseases, to clarify its differences in atopic and non atopic bronchial asthma and to determine the role of an Interleukin -13 receptor alpha 1 (IL-13 Rα1) gene Single Nucleotide Polymorphism (SNP) (A1398G) in the pathogenesis of these diseases.","PeriodicalId":331391,"journal":{"name":"Allergy Disorders & Therapy","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2017-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115013596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}